Form D · Other Health Care

Phreesia, Inc.

New York, NY · CIK 0001412408

Offering snapshot reported Dec 11, 2017 · SEC filing

Reported sold
$34M
Offering amount: $40M
Investors reported
4
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 27, 2017
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$17M$34MNov 8, 2017: $16,999,997.00Nov 8, 2017Dec 11, 2017: $33,999,994.00Dec 11, 2017

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$16,999,997 → $33,999,994

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 11, 2017Amendment$33,999,994$16,999,997vs Nov 8, 20174SEC filing
Nov 8, 2017Initial$16,999,997No comparison4SEC filing
Oct 27, 2014Initial$29,999,998No comparison5SEC filing
Aug 3, 2010Amendment$19,780,000$4,800,001vs Apr 23, 201010SEC filing
Apr 23, 2010Initial$14,979,999No comparison9SEC filing
Feb 23, 2009PaperNot reportedNo comparisonNot reportedSEC filing
Sep 11, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$1M (estimated)
Finders' fees
$0
Form D file number
021-298315
Allen & Company LLC may receive 5% of money raised plus expenses, excluding any funds received from existing stockholders.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Allen & Company LLC25

Source: Form D, filed Dec 11, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Thomas Altier Executive
Edward Cahill Director
William Conroy Director
Matthew Downs Director
Chaim Indig Director, Executive
Charles Kallenbach Executive
Victor Kats Director
Dusty Lieb Director
Rory Parness Executive
Scott Perricelli Director
Evan Roberts Executive
Alan Spoon Director
Michael Weintraub Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
432 Park Avenue S. 12 Th Floor
New York, NY, 10016